[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-365941-105":59,"doc-detail-365941-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","understanding-hpv-induced-cancers-and-investigating-the-barriers-faced-by-low-and-middle-income-countries-in-prevention-and-treatment","Understanding HPV-Induced Cancers and Investigating the Barriers Faced by Low-and Middle-Income Countries in Prevention and Treatment","","Human papillomavirus (HPV) drives multiple malignancies, especially cervical cancer, along with anal, penile, vulvar, vaginal, and oropharyngeal cancers. Although vaccines and screening can prevent disease effectively, HPV-related cancer burden remains disproportionately high in low- and middle-income countries (LMICs). This literature review synthesizes cancer types, biological mechanisms, treatments, and prevention approaches, while examining access and infrastructure gaps, vaccine hesitancy, funding shortages, and cultural stigma. It also discusses recent scientific and policy advances, including single-dose vaccination, self-sampling HPV testing, and senolytic therapies. By linking molecular biology with public health systems, the review supports interdisciplinary, equity-centered interventions and highlights the need for global collaboration and local action to reduce HPV-related inequities worldwide.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/understanding-hpv-induced-cancers-and-investigating-the-barriers-faced-by-low-and-middle-income-countries-in-prevention-and-treatment/365941/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/understanding-hpv-induced-cancers-and-investigating-the-barriers-faced-by-low-and-middle-income-countries-in-prevention-and-treatment/365941.png","ImageObject",300,407,{"name":92,"@type":93},"วิน","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Which cancers does HPV induce, according to the document?","Question",{"text":112,"@type":113},"HPV is described as a leading cause of cancers including cervical cancer, as well as anal, penile, vulvar, vaginal, and oropharyngeal malignancies.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Why does the review focus on low- and middle-income countries (LMICs)?",{"text":117,"@type":113},"The document states that prevention tools remain highly effective, yet the global burden of HPV-induced cancers stays disproportionately high in LMICs due to disparities in access and infrastructure.",{"name":119,"@type":110,"acceptedAnswer":120},"What barriers to prevention and treatment in LMICs does the review highlight?",{"text":121,"@type":113},"It highlights limited healthcare infrastructure, vaccine hesitancy, funding gaps, and cultural stigma that hinder adoption of life-saving interventions.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},365941,1790496383,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},2336475104736,"https://ap-avatar.wpscdn.com/avatar/22000c4c5e0e5b17e70?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786591360781797222","Review  \nUnderstanding HPV-Induced Cancers and Investigating the Barriers Faced by Low-and Middle-Income Countries in Prevention and Treatment  \nZahab N. Aleezada, Ishika Patel  and Nabiha Yusuf *  \nAcademic Editor: Marco Ciotti  \nReceived: 7 May 2025  \nRevised: 6 June 2025  \nAccepted: 6 June 2025  \nPublished: 11 June 2025  \nCitation: Aleezada, Z.N.; Patel, I.; Yusuf, N. Understanding  \nHPV-Induced Cancers and Investigating the Barriers Faced by Low-and Middle-Income Countries in Prevention and Treatment. Int. J. Mol. Sci. 2025, 26, 5581. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/ijms26125581](10.3390/ijms26125581)  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \nHeersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA  \n* [Correspondence: nabihayusuf@uabmc.edu](Correspondence: nabihayusuf@uabmc.edu); Tel.: +1-205-934-7432  \nAbstract: Human papillomavirus (HPV) is a leading cause of several cancers, most notably cervical cancer, but also anal, penile, vulvar, vaginal, and oropharyngeal malignancies. While vaccines and screening technologies offer highly effective prevention, the global burden of HPV-induced cancers remains disproportionately high in low-and middleincome countries (LMICs) . This literature review provides a comprehensive synthesis of the types, mechanisms, treatments, and prevention strategies associated with HPV-related cancers, while also highlighting regional disparities in healthcare access and infrastructure. It critically examines the barriers LMICs face in adopting life-saving interventions, such as limited healthcare infrastructure, vaccine hesitancy, funding gaps, and cultural stigma. The review further explores recent scientific and policy advances—including single-dose vaccination, self-sampling HPV tests, and senolytic therapies—that have the potential to reduce global health inequities. By connecting molecular biology with public health systems, this paper underscores the need for interdisciplinary solutions and equity-centered approaches to combat HPV-induced cancers worldwide. The findings emphasize that eliminating cervical cancer and other HPV-related diseases is not only a scientific goal but also a moral imperative requiring global collaboration and local action.  \nKeywords: HPV; cervical cancer; LMICs; vaccine access; screening; senolytics; public health; healthcare disparity; prevention; global oncology  \n1. Introduction  \nHuman papillomavirus (HPV) is a well-established etiological factor for multiple types of cancers, most notably cervical cancer. However, increasing evidence highlightsits role in a range of anogenital and oropharyngeal malignancies [1] . HPV and its various subtypes come from the viral family Papillomaviridae. These viruses are non-enveloped, and their genome structure consists of double-stranded DNA, which is then encased by an icosahedral capsid. Due to the structural nature of the virus, it is highly tissue-specific and infects both cutaneous and mucosal epithelia [2] . Among the various known HPV types, a subset of high-risk types—particularly HPV-16 and HPV-18—are responsible for the majority of cervical cancer cases worldwide [3] . The classification of HPV-induced cancers is crucial for understanding their distinct pathological features, guiding prevention efforts, and tailoring treatment strategies [4] .  \n2. Epidemiology  \nHPV is one of the most common sexually transmitted infections worldwide, with an estimated 85% of sexually active women and 91% of men acquiring the virus during their  \nlifetime [5] . Globally, HPV is responsible for approximately 5% of all cancers, including virtually all cases of cervical cancer ","cbCaib5HlH5y0Ejr","https://ap.wps.com/l/cbCaib5HlH5y0Ejr","pdf",736226,12,"English","# Introduction\n# Epidemiology","[{\"question\":\"Which cancers does HPV induce, according to the document?\",\"answer\":\"HPV is described as a leading cause of cancers including cervical cancer, as well as anal, penile, vulvar, vaginal, and oropharyngeal malignancies.\"},{\"question\":\"Why does the review focus on low- and middle-income countries (LMICs)?\",\"answer\":\"The document states that prevention tools remain highly effective, yet the global burden of HPV-induced cancers stays disproportionately high in LMICs due to disparities in access and infrastructure.\"},{\"question\":\"What barriers to prevention and treatment in LMICs does the review highlight?\",\"answer\":\"It highlights limited healthcare infrastructure, vaccine hesitancy, funding gaps, and cultural stigma that hinder adoption of life-saving interventions.\"}]","Understanding HPV-Induced Cancers and Investigating the Barriers Faced by Low-and Middle-Income Countries in Prevention and Treatment | PDF",1790163039,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9b262fc409ae748e409ac5f7a6a256b3.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2c1f79f15b99d3e68d2ee68704afce11.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/618c367675afd2c960407f71d14d4af1.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/39449830d50865894269f942f5ab30ad.webp",980,1385]